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Background
Cross-reactive neutralizing activity (CrNA) is elicited in
around 30% of HIV-1 infected individuals and is most
likely directed against conserved regions of the envelope
glycoprotein complex (Env). We hypothesized that the
induction of CrNA may at least to a certain extent
depend on the phenotypic characteristics of Env from
viruses early in infection.
Methods
We selected 34 patients from the Amsterdam Cohort
Studies (ACS) who had varying levels of CrNA at 2-4
years after seroconversion (SC). We retrospectively gen-
erated Env sequences from clonal HIV-1 variants that
were isolated between 2 and 14 months after SC and
analyzed the length of the variable regions and the num-
ber of potential N-linked glycosylation sites (PNGS).
Results
For 31 out of 34 patients we observed a correlation
between a higher level of CrNA and on one hand a
shorter variable region 1 (P=0.04) and on the other
hand a increased number of NXS sequons relative to
the number of PNGS (P=0.04), which decreases the
probability of glycosylation at that site. In contrast, in
the 3 patients with the most potent CrNA, defined as
elite neutralizers, the viral V1 region was longer with a
higher number of NXT sequons relative to the number
of PNGS. These viral characteristics are similar to those
in patients with low potency of CrNA, rather than to
those in patients with higher potency of CrNA in their
serum.
Conclusion
Our results suggest that in general the development of
CrNA in HIV-1 infected patients is associated with a
more open structure of the viral Env, mediated by a
short V1 loop and a low probability of glycosylation.
However, our three elite neutralizers were exceptions to
this rule. The identification and understanding of Env
characteristics that are involved in the development of
CrNA should help the rational design of an effective
antibody-based vaccine immunogen.
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